Gastric prostacyclin (PGI2) prevents stress-induced gastric mucosal injury in rats by inhibiting leukocyte activation.
Harada
N
N
Department of Emergency and Critical Care Medicine, School of Medicine, Fukuoka University, Japan.
Okajima
K
K
Murakami
K
K
Liu
W
W
Isobe
H
H
Tanaka
K
K
Okabe
H
H
D000818:Animals; D011464:Epoprostenol / Q000502:physiology*; D005753:Gastric Mucosa / Q000098:blood supply / Q000473:pathology / Q000502:physiology*; D007101:Immersion; D007213:Indomethacin / Q000494:pharmacology*; D008297:Male; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D009195:Peroxidase / Q000378:metabolism*; D011460:Prostaglandins F / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow / Q000187:drug effects; D012149:Restraint, Physical; D013315:Stress, Psychological / Q000473:pathology / Q000503:physiopathology*
D011460:Prostaglandins F; D011464:Epoprostenol; D009195:Peroxidase; C100006:prostaglandin F1; D007213:Indomethacin